Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis Source: ERJ Open Res, 5 (4) 00051-2019; 10.1183/23120541.00051-2019 Year: 2019
Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs Source: Eur Respir J, 55 (1) 1901472; 10.1183/13993003.01472-2019 Year: 2020
Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania Source: Eur Respir J 2009; 33: 1216-1219 Year: 2009
Isolation of Achromobacter xylosoxidans from the respiratory secretions of patients with cystic fibrosis: frequency in the population and significance to the progression of lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 402s Year: 2005
Achromobacter xylosoxidans strains with shared genotype among patients attending a cystic fibrosis (CF) rehabilitation centreSource: Eur Respir J 2005; 26: Suppl. 49, 596s Year: 2005
Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevanceSource: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005
Haemophilus influenzae biofilms in primary ciliary dyskinesia: a moving storySource: Eur Respir J, 50 (3) 1701369; 10.1183/13993003.01369-2017 Year: 2017
Number of exacerbations and Pseudomonas aeruginosa colonization negatively impact on the radiological severity in Primary Ciliary Dyskinesia. Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2006; 27: 653 Year: 2006
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017
Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation Source: Eur Respir J, 50 (3) 1700612; 10.1183/13993003.00612-2017 Year: 2017
The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflectionsSource: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021
Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006
Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients Source: Eur Respir J 2004; 23: 98-102 Year: 2004
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002
Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013